Coastlands Capital Lp
10% Owner at Adial Pharmaceuticals, Inc. (ADIL); 10% Owner at Pasithea Therapeutics Corp. (KTTA)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
77
Avg. 90-day return+21.2%
vs. S&P 500+17.7%
Beat the market50%
Paper profit on buys+$43K
Total bought / sold$159K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 16SEC | ADILAdial Pharmaceuticals, Inc. | Buy | 2,000387,075 held (+1%) | $2.65 | $5K | +47.2% |
| Jul 16SEC | ADILAdial Pharmaceuticals, Inc. | Buy | 1,233388,308 held (+0%) | $2.75 | $3K | +41.8% |
| Jul 13SEC | ADILAdial Pharmaceuticals, Inc. | Buy | 10,053383,375 held (+3%) | $2.79 | $28K | +39.8% |
| Jul 13SEC | ADILAdial Pharmaceuticals, Inc. | Buy | 1,700385,075 held (+0%) | $2.70 | $5K | +44.4% |
| Jul 1SEC | ADILAdial Pharmaceuticals, Inc. | Buy | 25,000373,322 held (+7%) | $2.60 | $65K | +50.0% |
| Jun 22SEC | KTTAPasithea Therapeutics Corp. | Buy | 100,0003,835,035 held (+3%) | $0.53 | $53K | -11.7% |
- Buy
10% Owner Coastlands Capital Lp bought $65K of ADIL at $2.60 — first open-market purchase in our records.
- Buy
10% Owner Coastlands Capital Lp bought $53K of KTTA at $0.53 — first open-market purchase in our records.